Serge Belanger Score: 20
Analyst at
Needham
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+13.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
38%
6 W / 10 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
33%
4 W / 8 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 11 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
38%
6 W / 10 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
38%
6 W / 10 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 07, 2026 |
Cytokinetics Inc
CYTK
|
BUY |
$112.00
Est. +47%
|
$76.32 | $81.37 |
Pending
|
$65.66
-14.0%
|
| May 08, 2026 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$78.00
Est. +38%
|
$56.55 | $72.66 |
Pending
|
$38.06
-32.7%
|
| Dec 22, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$84.00
Est. +21%
|
$69.25 | $88.31 |
Target Met
|
$65.66
-5.2%
|
| Sep 30, 2025 |
MoonLake Immunotherapeutics - Ordinary Shares - Class A
MLTX
|
BUY |
$20.00
Est. +220%
|
$6.25 | $23.29 |
Target Met
|
$12.12
+93.9%
|
| Jan 09, 2025 |
Liquidia Corp
LQDA
|
BUY |
$19.00
Est. +53%
|
$12.40 | $38.16 |
Target Met
|
$70.95
+472.2%
|
| Nov 05, 2024 |
KalVista Pharmaceuticals Inc
KALV
|
BUY |
$28.00
Est. +149%
|
$11.25 | $17.28 |
Miss
|
$27.00
+140.0%
|
| Sep 11, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$38.00
Est. +300%
|
$9.51 | $27.20 |
Miss
|
$20.66
+117.2%
|
| Aug 28, 2024 |
NewAmsterdam Pharma Company NV
NAMS
|
BUY |
$36.00
Est. +115%
|
$16.77 | $27.29 |
Miss
|
$22.74
+35.6%
|
| May 23, 2024 |
Cytokinetics Inc
CYTK
|
BUY |
$72.00
Est. +22%
|
$59.23 | $61.37 |
Miss
|
$65.66
+10.9%
|
| May 15, 2024 |
Arcutis Biotherapeutics Inc
ARQT
|
BUY |
$18.00
Est. +121%
|
$8.13 | $17.75 |
Precision Hit (±3%)
|
$26.27
+223.1%
|
| Mar 13, 2024 |
Heron Therapeutics Inc
HRTX
|
BUY |
$5.00
Est. +66%
|
$3.01 | $3.73 |
Miss
|
$0.29
-90.4%
|
| Sep 20, 2023 |
Revance Therapeutics Inc
RVNC
|
BUY |
$35.00
Est. +160%
|
$13.48 | $6.65 |
Miss
|
$3.65
-72.9%
|
| Aug 31, 2023 |
MoonLake Immunotherapeutics - Ordinary Shares - Class A
MLTX
|
BUY |
$76.00
Est. +35%
|
$56.10 | $50.53 |
Miss
|
$12.12
-78.4%
|
| Jul 25, 2023 |
Verrica Pharmaceuticals Inc
VRCA
|
BUY |
$10.00
Est. +88%
|
$5.32 | $8.98 |
Miss
|
$4.36
-18.0%
|
| May 04, 2022 |
Esperion Therapeutics Inc.
ESPR
|
BUY |
$12.00
Est. +84%
|
$6.53 | - | - |
$3.18
-51.3%
|
| Mar 03, 2022 |
Akebia Therapeutics Inc.
AKBA
|
BUY |
$7.00
Est. +164%
|
$2.65 | - | - |
$0.92
-65.3%
|
Cytokinetics Inc
CYTK
Aug 07, 2026
Signal & Target
BUY
$112.00
Start Price
$76.32
Best Price (1Y)
$81.37
Current Price
$65.66
Return
-14.0%
Xenon Pharmaceuticals Inc
XENE
May 08, 2026
Signal & Target
BUY
$78.00
Start Price
$56.55
Best Price (1Y)
$72.66
Current Price
$38.06
Return
-32.7%
Cytokinetics Inc
CYTK
Dec 22, 2025
Signal & Target
BUY
$84.00
Start Price
$69.25
Best Price (1Y)
$88.31
Current Price
$65.66
Return
-5.2%
Signal & Target
BUY
$20.00
Start Price
$6.25
Best Price (1Y)
$23.29
Current Price
$12.12
Return
+93.9%
Liquidia Corp
LQDA
Jan 09, 2025
Signal & Target
BUY
$19.00
Start Price
$12.40
Best Price (1Y)
$38.16
Current Price
$70.95
Return
+472.2%
KalVista Pharmaceuticals Inc
KALV
Nov 05, 2024
Signal & Target
BUY
$28.00
Start Price
$11.25
Best Price (1Y)
$17.28
Current Price
$27.00
Return
+140.0%
Viridian Therapeutics Inc
VRDN
Sep 11, 2024
Signal & Target
BUY
$38.00
Start Price
$9.51
Best Price (1Y)
$27.20
Current Price
$20.66
Return
+117.2%
NewAmsterdam Pharma Company NV
NAMS
Aug 28, 2024
Signal & Target
BUY
$36.00
Start Price
$16.77
Best Price (1Y)
$27.29
Current Price
$22.74
Return
+35.6%
Cytokinetics Inc
CYTK
May 23, 2024
Signal & Target
BUY
$72.00
Start Price
$59.23
Best Price (1Y)
$61.37
Current Price
$65.66
Return
+10.9%
Arcutis Biotherapeutics Inc
ARQT
May 15, 2024
Signal & Target
BUY
$18.00
Start Price
$8.13
Best Price (1Y)
$17.75
Current Price
$26.27
Return
+223.1%
Heron Therapeutics Inc
HRTX
Mar 13, 2024
Signal & Target
BUY
$5.00
Start Price
$3.01
Best Price (1Y)
$3.73
Current Price
$0.29
Return
-90.4%
Revance Therapeutics Inc
RVNC
Sep 20, 2023
Signal & Target
BUY
$35.00
Start Price
$13.48
Best Price (1Y)
$6.65
Current Price
$3.65
Return
-72.9%
Signal & Target
BUY
$76.00
Start Price
$56.10
Best Price (1Y)
$50.53
Current Price
$12.12
Return
-78.4%
Verrica Pharmaceuticals Inc
VRCA
Jul 25, 2023
Signal & Target
BUY
$10.00
Start Price
$5.32
Best Price (1Y)
$8.98
Current Price
$4.36
Return
-18.0%
Esperion Therapeutics Inc.
ESPR
May 04, 2022
Signal & Target
BUY
$12.00
Start Price
$6.53
Best Price (1Y)
-
Current Price
$3.18
Return
-51.3%
Akebia Therapeutics Inc.
AKBA
Mar 03, 2022
Signal & Target
BUY
$7.00
Start Price
$2.65
Best Price (1Y)
-
Current Price
$0.92
Return
-65.3%